Lv1
92 积分 2025-09-21 加入
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
15天前
已完结
The utility of non‐invasive tests to assess advanced fibrosis in Asian subjects with chronic hepatitis B and concomitant hepatic steatosis
16天前
已完结
All-cause and cause-specific mortality in patients with chronic hepatitis B and concurrent steatotic liver disease
16天前
已完结
Comparing the Hospital Frailty Risk Score and the Clinical Frailty Scale Among Older Adults With Chronic Obstructive Pulmonary Disease Exacerbation
19天前
已完结
Frailty and Effects of a Multidomain Physical Rehabilitation Intervention Among Older Patients Hospitalized for Acute Heart Failure
19天前
已完结
Clinical Characteristics and Outcome of Drug‐Induced Liver Injury in the Older Patients: From the Young‐Old to the Oldest‐Old
30天前
已完结
PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial
2个月前
已完结
Transarterial chemoembolization combined with Huaier granule for the treatment of primary hepatic carcinoma
4个月前
已完结
Effect of decoction of Fuzheng Jiedu Xiaoji formula plus chemoembolization on primary liver cancer in patients
4个月前
已完结
Traditional Chinese medicine in the treatment of adverse reactions after TACE for primary hepatic carcinoma: Effect, mechanism, and potential advantages
4个月前
已完结
皖公网安备34019202002308
